Codeium hits Unicorn status with $150m Series C round: What this means for the future of AI coding platforms
Codeium, the innovative AI-powered coding platform, has reached a significant milestone with its recent $150 million Series C funding round. This latest investment pushes the ... Read More
Nearfield Instruments lands mammoth €135m to revolutionize semiconductor tech
Nearfield Instruments, a leader in Metrology & Inspection (M&I) solutions, has announced a colossal €135 million Series-C funding round. Spearheaded by industry giants Walden Catalyst ... Read More
Odaseva rakes in $54m in Series C to enhance Salesforce data security solutions
Odaseva, the leader in enterprise data security for Salesforce, has announced a significant $54 million Series C equity financing, raising its total funding to over ... Read More
Vitesse rakes in $93m in Series C funding to fuel expansion and innovation
Vitesse, a prominent provider of treasury and payment solutions tailored for the insurance sector, has closed a $93 million Series C funding round. This substantial ... Read More
Brim Financial secures $85m in Series C to fuel US expansion and product development
In a significant move within the fintech infrastructure landscape, Brim Financial ("Brim"), a pivotal company transforming credit card platforms and payment automation, announced the successful ... Read More
Bear Robotics secures $60m in Series C funding led by LG Electronics
Bear Robotics, a pioneering Silicon Valley company specializing in service robotics and artificial intelligence solutions, has announced the successful closure of a $60 million Series ... Read More
Galecto Biotech secures €79m in Series C funding to advance idiopathic pulmonary fibrosis treatment
Galecto Biotech, a Denmark-based pharmaceutical company specializing in galectin modulators for severe diseases like idiopathic pulmonary fibrosis (IPF) and cancer, has successfully raised €79 million ... Read More
Orchard Therapeutics raises $150m in Series C funding to advance gene therapies for rare diseases
Orchard Therapeutics, a leader in gene therapy specializing in rare diseases, has successfully secured $150 million through a Series C funding round. This substantial capital ... Read More